Insider · CIK 0001529409

Daniel William F

Reports to the SEC for 1 company · DUBLIN, L2

sec.gov

Transactions

Companies

Filings

CIK

0001529409

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−31.9K sh	$116.50	−$3.72M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−47.7K sh	$116.50	−$5.55M	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,548 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.1K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-07-27	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,016 sh	—	—	4,016
2023-04-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+3,913 sh	—	—	33,794
2023-04-28	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,879 sh	$111.16	−$209K	31,915
2023-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,913 sh	—	—	0
2022-04-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+4,223 sh	—	—	78,690
2022-04-29	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,139 sh	$98.56	−$112K	77,551
2022-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,223 sh	—	—	0
2022-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+3,913 sh	—	—	3,913
2021-05-10	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$12.70	+$254K	20,000
2021-05-10	Horizon Therapeutics Public Ltd CoS Sale	Director	SSale	−19.8K sh	$86.56	−$1.72M	166
2021-05-10	Horizon Therapeutics Public Ltd CoS Sale	Director	SSale	−166 sh	$87.01	−$14.4K	0
2021-05-10	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	13,286
2021-04-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	—	—	77,460
2021-04-30	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−2,993 sh	$94.62	−$283K	74,467
2021-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2021-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,223 sh	—	—	4,223
2020-05-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.4K sh	—	—	70,513
2020-05-02	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,151 sh	$35.62	−$148K	66,362
2020-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.4K sh	—	—	0
2020-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+11.1K sh	—	—	11,098
2019-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.3K sh	—	—	59,255
2019-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,132 sh	$26.54	−$110K	55,123
2019-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.3K sh	—	—	0
2019-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+15.4K sh	—	—	15,390
2018-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14.1K sh	—	—	43,935
2018-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.1K sh	—	—	0
2018-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+32.2K sh	—	—	32,161
2018-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+15.3K sh	—	—	15,320
2017-09-19	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+7,874 sh	—	—	32,262
2017-09-19	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−2,381 sh	$12.10	−$28.8K	29,881
2017-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,874 sh	—	—	0
2017-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14K sh	—	—	28,607
2017-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,219 sh	$15.12	−$63.8K	24,388
2017-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14K sh	—	—	0
2017-05-03	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	Director	AAward	+31.2K sh	—	—	31,153
2017-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+14.1K sh	—	—	14,054
2016-09-19	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+7,874 sh	—	—	17,035
2016-09-19	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−2,381 sh	$19.12	−$45.5K	14,654
2016-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,874 sh	—	—	7,874
2016-05-06	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+5,258 sh	—	—	10,751
2016-05-06	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,590 sh	$13.41	−$21.3K	9,161
2016-05-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,258 sh	—	—	0

Recent filings

Accepted (ET)
Oct 64
Daniel William F0001209191-23-052372
SEC(opens sec.gov)
Jul 284
Daniel William F0001209191-23-043692
SEC(opens sec.gov)
May 24
Daniel William F0001209191-23-026754
SEC(opens sec.gov)
May 24
Daniel William F0001209191-22-026464
SEC(opens sec.gov)
May 124
Daniel William F0001209191-21-032095
SEC(opens sec.gov)

Companies

Horizon Therapeutics Public Ltd CoDirector

Address

C/O HORIZON PHARMA PLC ADELAIDE CHAMBERS, PETER STREET

DUBLIN, L2, 8